Retracted: Lovastatin Inhibits RhoA to Suppress Canonical Wnt/β-Catenin Signaling and Alternative Wnt-YAP/TAZ Signaling in Colon Cancer
- DOI
- 10.1177/09636897221075749
- Published
- 2022-01
- Container
- Cell Transplantation
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1177/09636897221075749,
title = {Retracted: Lovastatin Inhibits RhoA to Suppress Canonical Wnt/β-Catenin Signaling and Alternative Wnt-YAP/TAZ Signaling in Colon Cancer},
author = {Yi Xiao and Qin Liu and Nanyin Peng and Yuzhang Li and Danyang Qiu and Tianlun Yang and Richard Kang and Ahsan Usmani and Efosa Amadasu and Cesario V. Borlongan and Guolong Yu},
year = {2022},
journal = {Cell Transplantation},
doi = {10.1177/09636897221075749},
url = {https://doi.org/10.1177/09636897221075749}
}RIS
TY - JOUR TI - Retracted: Lovastatin Inhibits RhoA to Suppress Canonical Wnt/β-Catenin Signaling and Alternative Wnt-YAP/TAZ Signaling in Colon Cancer AU - Yi Xiao AU - Qin Liu AU - Nanyin Peng AU - Yuzhang Li AU - Danyang Qiu AU - Tianlun Yang AU - Richard Kang AU - Ahsan Usmani AU - Efosa Amadasu AU - Cesario V. Borlongan AU - Guolong Yu PY - 2022 JO - Cell Transplantation DO - 10.1177/09636897221075749 UR - https://doi.org/10.1177/09636897221075749 ER -
APA
Xiao, Y., Liu, Q., Peng, N., Li, Y., Qiu, D., Yang, T., Kang, R., Usmani, A., Amadasu, E., Borlongan, C. V., & Yu, G. (2022). Retracted: Lovastatin Inhibits RhoA to Suppress Canonical Wnt/β-Catenin Signaling and Alternative Wnt-YAP/TAZ Signaling in Colon Cancer. Cell Transplantation. https://doi.org/10.1177/09636897221075749
Source records
- crossref · retrieved 2026-09-25T23:01:53.936Z